1. Home
  2. SQNS vs IMUX Comparison

SQNS vs IMUX Comparison

Compare SQNS & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.13

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.24

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
IMUX
Founded
2003
2016
Country
France
United States
Employees
N/A
66
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
75.2M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
SQNS
IMUX
Price
$3.13
$1.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$20.33
$4.25
AVG Volume (30 Days)
151.1K
4.6M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$62.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.51
52 Week High
$10.93
$1.35

Technical Indicators

Market Signals
Indicator
SQNS
IMUX
Relative Strength Index (RSI) 42.03 74.15
Support Level $2.72 $0.61
Resistance Level $5.85 N/A
Average True Range (ATR) 0.22 0.10
MACD 0.10 0.03
Stochastic Oscillator 76.36 89.79

Price Performance

Historical Comparison
SQNS
IMUX

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: